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Introduction
CMR has become the leading technique to define the clin-
ical impact of hypertrophic cardiomyopathy (HCM) pro-
viding complete coverage of both ventricles with high
spatial resolution. Gadolinium delayed-hyperenhance-
ment (DHE) accurately identifies regions of myocardial
fibrosis. Via CMR, innumerable studies have established
that LVH is the predominant phenotypic expression of
HCM. It is well known that myocardial fibrosis can occur
in HCM patients and is independently linked to a poorer
prognosis than those without fibrosis by CMR. The geno-
typic expressions would appear to affect the entire heart
yet, classically, investigations have been limited to the LV,
in some part due to inability to image the smaller, thinner
RV. Thus, little information is available about the RV in
HCM.
Purpose
We hypothesize there is significant RV involvement in
HCM when incorporating a CMR analysis for RV hyper-
trophy and fibrosis.
Methods
Review of all patients referred for HCM was performed.
SSFP/DHE was used to diagnose patients with HCM,
using gadolinium administration (0.15mmol/kg, Multi-
Hance, Bracco Diagnostics, Princeton,NJ). Post-injection
(2/10 minutes) DHE images were obtained using manual
T1-weighted, inversion recovery preparations. Regions of
myocardium with abnormally high signals were desig-
nated as fibrotic. LV/RV mass indices (LVMI/RVMI) were
calculated. Fibrosis was semi-quantitatively assessed in
both ventricles.
Results
Via 44 patients referred for HCM from 2006-2010, 15
(34%) were CMR confirmed. Image quality was judged
excellent in14/15 (93%). The mean LVMI was 86±26gm2
(>2SD >normal) while the mean RVMI was 23±6gm2
(1SD >normal). All patients met formal LVH criteria while
6/15 (40%) met RVH criteria. 12/15 (80%) had evidence
of LV fibrosis while 9/15 (60%) had evidence for RV fibro-
sis (Figure 1). No patient with RV fibrosis had absent LV
fibrosis. In neither LV nor RV was there a difference in the
degree of hypertrophy as to prediction of likelihood for
fibrosis (88±28 vs.83±25g/m2 and 21±5 vs.23±6g/m2,
respectively) but on average, DHE+ patients had more,
not less hypertrophy.
Conclusions
The frequency of RVH/fibrosis in the setting of HCM is
surprising in that this phenomenon is rarely, if ever,
described. However, given the genetic abnormalities,
there is no reason to expect phenotypic expression should
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be limited to the LV. Interestingly, similar to the LV, the
degree of RVH had little predictive power towards the
finding of DHE-defined RV fibrosis. When considering
HCM, it is important to recognize that the pathology is
not limited to the LV and CMR resolution helps remind us
of the concordance between the two ventricles.
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